Ocugen On Track to Submit Emergency Use Authorization Application to U.S. FDA for its COVID-19 Vaccine Candidate, COVAXIN™GlobeNewsWire • 05/27/21
Take a Look at Ocugen's Work on Eye Diseases, Not Just Their Vaccine PartnershipInvestorPlace • 05/11/21
3 Investments That Turned $35,000 Into $1 Million (or More) in Just 6 MonthsThe Motley Fool • 05/08/21
Ocugen's (OCGN) CEO Shankar Musunuri on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/08/21